September 8, 2020 02:59 PM EDTUpdated September 9, 10:23 AM

Pharma's battered rep gets a modest facelift in the latest industry ratings from Gallup — but it's still looking pretty bad

When the pandemic started up earlier this year, quite a few pharma execs felt it was the perfect opportunity to mend fences with the American …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

Phar­ma's bat­tered rep gets a mod­est facelift in the lat­est in­dus­try rat­ings from Gallup — but it's still look­ing pret­ty bad